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Summary Basal cell carcinomas (BCCs) are very frequent cutaneous cancers, often located on the face. Cure rates with surgery and
radiotherapy are high, but these treatments have never been compared prospectively. A randomized trial was initiated in 1982 to compare
surgery and radiotherapy in the treatment of primary BCC of the face measuring less than 4 cm. The primary end point was the failure rate
(persistent or recurrent disease) after 4 years of follow-up. The secondary end point was the cosmetic results assessed by the patient, the
dermatologist and three persons not involved in the trial. In the course of the trial, 347 patients were treated. Of the 174 patients in the surgery
group, 71% had local anaesthesia and 91% frozen section examination. Of the 173 patients in the radiotherapy group, 55% were treated with
interstitial brachytherapy, 33% with contactherapy and 12% with conventional radiotherapy. The 4-year actuarial failure rate (95% Cl) was
0.7% (0.1-3.9%) in the surgery group compared with 7.5% (4.2-13.1%) in the radiotherapy group (log-rank P= 0.003). The cosmetic results
assessed by four of the five judges were significantly better after surgery than after radiotherapy. Eighty-seven per cent of the surgery-treated
patients and 69% of the radiation-treated patients considered the cosmetic result as good (P< 0.01). Thus, in the treatment of BCC of the face
of less than 4 cm in diameter, surgery should be preferred to radiotherapy.
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Basal cell carcinomas (BCCs) are the most frequent cutaneous
cancers among white people, accounting for over 70% of all cases
(Coebergh et al, 1991; Ko et al, 1994). Several studies have shown
a recent increase in incidence (Fears and Scotto 1982; Levi et al,
1988; Gallagher et al, 1990; Coebergh et al, 1991; Ko et al, 1994).
The head and neck are the most affected sites, accounting for
around 70% of all cases (Levi et al, 1988; Gallagher et al, 1990;
Coebergh et al, 1991). Several therapeutic modalities are used
to treat this neoplasm: radiotherapy, excisional surgery, Mohs
surgery, electrodesiccation with curettage and cryosurgery. The
choice ofthe treatment technique is contingent on various factors,
such as tumourcharacteristics, the general condition ofthe patient,
cosmetic considerations, skill and the preference ofthe physicians.
Surgical excision and radiation therapy are commonly used for
treatment of primary BCC (Fleming et al, 1995; Committee on
Guidelines of Care and Task Force on Basal Cell Carcinoma,
1992). These methods achieve cure rates ofbetween 90% and 98%
(Rowe et al, 1989; Silverman et al, 1991; Goldberg 1996) but have
never been compared prospectively (Preston and Stern 1992;
Fleming et al, 1995; Goldberg 1996). Surgery is more commonly
used than radiotherapy, but in some regions of the face (eyelids,
nose, ear) radiotherapy has been recommended because of
cosmetic reasons.
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In 1982, a prospective, randomized trial was initiated at the
Gustave Roussy Institute to compare surgery and radiotherapy in
the treatment ofprimary BCC ofthe face. The main end point was
the cure rate after 4 years of follow-up; the secondary end point
was cosmetic results.
PATIENTS AND METHODS
Eligibility and study design
The criterion for inclusion was the presence of a previously
untreated BCC of the face, confirmed by biopsy, with the largest
diameter below 4 cm. Further eligibility criteria included no
contraindication to surgery and radiotherapy, and informed consent.
Patients with BCC located on the scalp orthe neck, patients who had
total removal ofBCC atbiopsy, patients with five or more BCCs and
patients with a life expectancy ofbelow 3 years were not eligible.
Treatment methods
Patients were randomly allocated to surgery or radiotherapy by
means of sequential sealed envelopes opened by the trial data
manager. In case of multiple primary BCCs, the largest tumour
was assigned to the trial and the others were treated with the same
technique.
Surgery
Surgical treatment consisted in the resection of the whole tumour
with a free margin of at least 2 mm from the visible borders.
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Table 1 Characteristics of initial BCC
Characteristics Surgery Radiotherapy
(n = 174) (n = 173)
Number of patients (%)
BCC clinical type
Nodular 79 (45) 74 (43)
Ulcerated 52 (30) 50 (29)
Superficial and pagetoid 36 (21) 41 (23)
Sclerosing 7 (4) 8 (5)
Other clinical characteristics
Infiltration determined clinicallya 45 (26) 60 (35)
Well-defined limits 86 (49) 95 (55)
Largest diameter (mm)
3-5 19 (11) 17 (10)
6-10 87 (50) 75 (43)
11-20 58 (33) 68 (39)
21-30 8 (5) 12 (7)
31-40 2 (1) 1 (1)
Site
Nose 53 (30) 49 (28)
Cheek, pre- and retroauricular areas 36 (21) 42 (24)
Eyelids, internal and external eye angles 34 (19) 35 (20)
Forehead, temple, between eyebrows 36 (21) 29 (17)
Chin, cutaneous superior lip 10 (6) 12 (7)
Ear 5 (3) 6 (3)
ap = 0.07
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Figure 1 Kaplan-Meier plot of recurrent or persistent BCC in patients
treated with surgery or radiotherapy. Bars indicate 95% confidence intervals.
- - -, Surgery (n = 174, one event); -, radiotherapy (n = 173, 11 events)
Frozen sections could be performed at the surgeon's request.
Multiple frozen sections of lateral and deep margins were exam-
ined to determine whether excision was complete. In case of
involved margins, one or more additional cutaneous excisions
were performed, based on successive histological examinations,
until margins were totally free of disease. Wound closure was
either by direct suture, or by using various skin flaps or thin or
thick-skin grafts, according to the location and size ofthe BCC. A
final histological assessment of paraffin-embedded sections was
performed within the following week.
Radiotherapy
Three radiation techniques were available: interstitial brachytherapy,
superficial contactherapy and conventional radiotherapy. The
radiotherapist chose the treatment technique according to tumour
parameters, location on the face (curved or plane surface) and
patient characteristics (age, performance status).
Interstitial brachytherapy was performed with iridium-192
wires afterloaded according to the methods described by Pierquin
(1987): the silk suture technique (method of choice), the plastic
tube technique (similar to the basic Henschke method) and the
hypodermic needle technique. A dose of 65-70 Gy was delivered
at the reference isodose, according to the Paris dosimetry method
(Dutreix et al, 1987), over a period of 5-7 days. The patient was
hospitalized throughout treatment.
Superficial contactherapy (50 kV) was performed with a
Phillips apparatus, with various localizers (15 or 20 mm in diam-
eter). The treatment schedule consisted of two sessions, each
delivering 18-20 Gy with a 2-week interval. This technique did
not require hospitalization, and was used for BCC of less than
2 cm in the largest diameter.
Conventional radiotherapy (85-250 kV) was performed with
either a Koch and Sterzel apparatus (85-250 kV) or an RT 250
Phillips apparatus (125-250 kV). The field size was delineated for
each case. Treatment fractions ranged from 2 to 4 Gy, delivered
3-4 times per week, up to a total dose of60 Gy. Patients were not
hospitalized.
For surgical treatment and interstitial brachytherapy, local
anaesthesia was performed as often as possible, taking into
account the patients' preference. In the other cases, general anaes-
thesia or neuroleptanalgesia was used.
Follow-up
Follow-up consultations were planned at 3, 6 and 12 months after
the end of treatment and thereafter yearly until the fourth year.
Patients were examined by a dermatologist and photographs ofthe
scar were taken at three standardized distances.
Assessment criteria
As BCC is not a life-threatening neoplasm, the main end point was
the rate of histologically confirmed persistent tumour or recur-
rence after 4 years of follow-up (failure rate). The second assess-
ment criterion was the cosmetic result. Just before each follow-up
visit and in the absence of all physicians implicated, the patient
noted his or her level of satisfaction on a 10-cm visual analogue
scale going from 'not satisfied' to 'satisfied'. In addition, the
dermatologist questioned the patient about the cosmetic result
(good, fairorbad) during each follow-up examination. The derma-
tologist noted how the scar appeared (slightly visible, clearly
marked or bad). The cosmetic result was also independently
assessed, from the photographs taken at each follow-up visit, by
three persons not involved in the trial (the photographer, a data
manager and a medical secretary) and blinded to the treatment.
They could choose between good, fair or bad cosmetic result.
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Table 2 Cosmetic results
3 months 6 months 12 months 24 months 36 months 48 months pa
Sg Rt Sg Rt Sg Rt Sg Rt Sg Rt Sg Rt
Patient scale b c d 0.004
Mean 8.8 8.8 8.9 8.6 9.1 8.8 9.1 8.6 9.0 8.3 9.1 8.1
(s.d.) (1.9) (1.8) (1.6) (1.8) (1.3) (1.5) (1.5) (2.1) (1.6) (2.0) (1.6) (2.0)
Patient
Cosmetic result b b c 0.05
Good (%) 75 74 79 73 83 76 84 74 82 69 87 69
Fair(%) 24 24 18 24 16 20 15 22 15 26 11 22
Bad(%) 1 2 3 3 1 3 1 4 3 5 2 8
Dermatologist
Scar c d d 0.0001
Slightly visible (%) 56 55 66 64 74 65 77 60 77 50 79 40
Clearly marked (%) 42 43 31 34 26 32 21 35 22 46 19 47
Bad (%) 2 2 3 2 0 3 1 5 1 4 2 13
Photographer
Cosmetic result b d d 0.0001
Good (%) 30 25 38 40 50 41 53 35 65 38 62 29
Fair (%) 36 42 38 36 35 36 34 45 19 41 27 39
Bad (%) 34 33 24 24 15 23 13 20 16 21 11 32
Data manager
Cosmetic result d c d 0.03
Good (%) 27 30 43 39 51 43 54 28 50 28 50 24
Fair (%) 42 43 37 46 32 42 33 55 37 55 37 48
Bad (%) 30 27 20 15 17 14 13 17 13 17 13 28
Secretary
Cosmetic result 0.14
Good (%) 33 45 52 51 52 49 54 41 50 43 54 35
Fair (%) 48 39 37 39 39 37 36 46 40 42 39 44
Bad (%) 19 16 11 10 9 14 10 13 10 15 7 21
Sg, surgery; Rt, radiotherapy; aGlobal comparison of surgery and radiotherapy for the 4 years of follow-up; if the global test was significant, comparisons of
surgery and radiotherapy were performed at each time; bO.01 < P < 0.05; c0.001 < P < 0.01; dp < 0.001.
Required number of patients Kempton, 1994) implemented in the BMDP 5V procedure. The
A sample of 260 patients was necessary to detect a difference of analysis of the other cosmetic variables, which were categorical,
was performed by the generalized least-squares method (Koch 10% in the failure rate (from 10% to 0%) with a two-tailed log- ea, 1977)rmemnei the Sa S CatMOD produre.cA et al, 1977) implemented in the SAS CATMOD procedure. As rank test with ax = 0.05 and m = 0.05. As a rate of patients lost to patients with missing cosmetic data at any assessment time were
follow-up of 25% was predicted, a sample of 350 patients was omitted from this analysis, only four times were taken into consid-
planned. This sample size allowed us to detect a 20% difference in eration (3, 12, 36 and 48 months).
the rate of good cosmetic result (between 60% and 80%) using a
two-tailed chi-square test with cx = 0.05 and f = 0.10.
RESULTS
Statistical analysis Between February 1982 and November 1988, 360 patients were
Actuarial failure rates were estimated with the Kaplan-Meier enrolled in the trial. Among them, 13 patients were not treated for
method (Kaplan and Meier, 1958) and their 95% confidence inter- the following reasons. In the surgery group, two decided to be
vals (95% CI) were calculated with the Rothman (1978) method. treated elsewhere, three refused treatment and one had seborrhoeic
The failure-free interval started from the date of randomization keratosis. In the radiotherapy group, one patient decided to be
to the date ofhistologically confirmed recurrent orpersistent carci- treated elsewhere and six refused treatment. The results presented
noma. Patients who died during the trial were censored at the date here thus concern 347 patients who were analysed within their
ofdeath. Patients lost to follow-up were censored at the date ofthe allocated treatment group. In each group, one patient refused the
last examination. The failure curves were compared with the log- allocated treatment and was treated by the other method.
rank test (Peto et al, 1977). Cox's model (Cox, 1972) was used to
compare the two groups with adjustment for the main initial Initial characteristics
tumour characteristics. In the cosmetic results analysis, the time
dependence of the data was taken into account. The results Men accounted for 50% ofthe sample. The mean age was 66 years
assessed by the visual analogue scale were compared using the (s.d. = 12). Five per cent of patients were younger than 45 years.
method of the restricted maximum likelihood (Brown and The clinical characteristics ofthe BCC before treatment (Table 1)
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Figure 2 Percentage of slightly visible scars assessed by the dermatologist,
from randomization up to 4 years, according to site. (A) Nose; (B) cheek
and periauricular area; (C) periocular area; (D) forehead and temple.
-_, Surgery; ---, radiotherapy
were similar in the two groups. The mean of the largest diameter
was 11.1 mm (s.d. = 5.7) in the surgical group and 11.7 mm (s.d. =
5.7) in the radiotherapy group. Only 7% of patients had a BCC
with the largest diameter exceeding 20 mm. Sites of treated BCC
were similar in the two groups.
Treatments
Among the 174 patients in the surgery group, one was treated by
conventional radiotherapy. Resection was performed under local
anaesthesia for 123 patients (71%). Frozen section examination
was performed in 158 cases (91%) and showed that additional
resection was necessary before closure in 67 cases (39%) (lateral
additional resection in 46 cases, depth resection in 11 cases and
both in ten cases). Wound closure was obtained using direct
sutures (48%) or flaps (46%). Nine patients (5%) had grafts, and
wounds healed spontaneously in two (1%). After definitive patho-
logical diagnosis, excision was considered complete in 160 cases
(92%), borderline (i.e. frozen section was free of disease but
embedded section was involved) in six cases (3%) and incomplete
in seven cases (5%), six ofwhich underwent furtherresection. The
mean duration of hospitalization for all patients was 2.8 days
(s.d. = 2.8), but only 76 (44%) were hospitalized. Five patients
required a further operation to rectify their graft and one additional
patient surgical treatment ofan ectropion.
Among the 173 patients intheradiotherapy group, 95 weretreated
with interstitial brachytherapy, 57 with contactherapy, 20 with
conventional radiotherapy and one with surgery. Contactherapy was
applied to smallerBCCs (8.4 mm, s.d. = 3.2),brachytherapy usedfor
intermediate sized BCCs (12.9 mm, s.d. = 5.8) and conventional
radiotherapy for the largest BCCs (15.5 mm, s.d. = 5.8).
For brachytherapy, the silk suture technique was used in 87
cases. The range ofthe doses delivered was 57-76 Gy. Forty-five
patients received 65 Gy and 27 received 70 Gy. Most ofthe time,
two or three radioactive lines were used (70 and 23 patients
respectively). Local anaesthesia was performed in 80 patients. The
mean duration ofhospitalization was 6.9 days (s.d. = 1.8).
The range of the dose delivered by contactherapy was 34-
40 Gy, with two-thirds ofthe patients receiving 36 Gy.
The doses delivered by conventional radiotherapy were 60 Gy
in 18 cases, 65 Gy in one case and 33 Gy in another case. The
duration oftreatment varied 5-7 weeks.
Follow-up
The mean duration of follow-up was 41 months (s.d. = 14) in the
two groups. The numbers of censored data (death and lost to
follow-up) were similar in the two groups: 41 in the surgery group
and 47 in the radiotherapy group.
Failure rate
Only onepatient had a recurrence in the surgery group, whereas 11
patients had either further progression of the tumour (three
patients) or recurrence (eight patients) in the radiotherapy group.
The failure rate was significantly (log-rank test P =0.003) lowerin
the surgery group than in the radiotherapy group (Figure 1). The
4-year actuarial failure rate (95% CI) was 0.7% (0.1-3.9%) in
the surgery group and 7.5% (4.2-13.1%) in the radiotherapy
group. After brachytherapy, contactherapy and conventional
radiotherapy, the failure rates were 8.8% (4.3-17.1%), 6.6%
(2.2-17.8%) and 5% (0.9-23.6%) respectively. With Cox's model,
which allowed adjustment for the initial characteristics ofthe BCC
(well- or ill-defined borders, infiltration, size, site), the relative
risk of failure between radiotherapy and surgery was still signifi-
cant (P = 0.001) at 11.7 (95% CI 1.5-91).
Cosmetic result
Table 2 shows the cosmetic appraisal. Cosmetic results were
significantly betterafter surgery than afterradiotherapy in the eyes
of the patient, the dermatologist, the photographer and the data
manager, throughout the period of follow-up. The difference,
although not significant, was also in favour of surgery for the
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medical secretary. Cosmetic results were similar in the two groups
immediately after treatment, then they improved in the surgical
group, and went on to become clearly better after 2 years of
follow-up, whereas they deteriorated or remained stable in the
radiotherapy group. At4 years, the patients assessed their cosmetic
results as good in 87% after surgery and in 69% afterradiotherapy;
likewise, the percentages recorded for a slightly visible scar
assessed by the dermatologist were 79% and 40% respectively for
the two groups. Moreover, the percentage ofgood cosmetic results
was higher after surgery than after radiotherapy for the four most
frequent locations of the face (nose; cheek and periauricular area;
periocular area; forehead and temple) (Figure 2).
During the first year after surgery, the main characteristics of
scars were deformations and constrictions, which tended to
decrease during the follow-up period, but continued to affect 25%
and 5% of the patients respectively at 4 years. After radiotherapy,
dyspigmentations and telangiectasia developed, involving more
than 65% of the patients at 4 years. Radiodystrophy concerned
41% of the patients at 4 years, and 5% of the patients in the radio-
therapy group had necrosis that did not occur after contactherapy.
Three ophthalmologic complications were observed: one ectro-
pion after surgery and one cataract and one lachrymal duct stenosis
after radiotherapy.
DISCUSSION
The present trial showed a significant advantage, in terms of cure
rate and also in terms of cosmetic results for primary BCC of the
face, for surgery as opposed to radiotherapy. Surgery and radio-
therapy were performed by experienced physicians who could
choose the most appropriate procedure in each treatment group,
according to the individual BCC characteristics. After 4 years of
follow-up, the failure rate was 0.7% in the surgical group and 7.5%
in the radiotherapy group, and the cosmetic results were assessed
as 'good' by 87% and 69% respectively of the patients in the two
groups. Several previous studies have reported cure rates and
cosmetic results with surgery and radiotherapy but this study is the
first randomized trial, thus giving an unbiased comparison of the
two treatments. It is also the first study in which cosmetic results
were assessed by observers not involved in the trial, in addition to
patients and dermatologist.
Failure rate
In our study, the failure rate after surgery was very low (0.7% at 4
years), lower than the published failure rates after surgical resec-
tion which range from 2% to 10% (Marchac and Duport, 1980;
Dubin and Kopf, 1983; Roenigk et al, 1986; Marchac, 1988; Ashby
et al, 1989; Rowe et al, 1989; Silverman et al, 1992a; Bonvallot et
al, 1993; Lawrence, 1993). It is closer to that obtained with Mohs
surgery, which is often below 2% (Tromovitch and Stegman, 1978;
Robins, 1981; Robins et al, 1985; Roenigk et al, 1986; Rowe et al,
1989; Lawrence, 1993; Hruza, 1994). In contrast to radiotherapy, a
histological appraisal of the efficiency of the treatment is possible
with surgery. When an incomplete resection is diagnosed based on
the embedded section, additional treatment or vigilant observation
should be discussed with each patient, because recurrence occurs in
only 25-50% ofthe cases and further treatment may prove difficult
for physical or psychological reasons (Richmond and Davie, 1987;
Liu et al, 1991; Preston and Stern, 1992). The frozen section exam-
ination, which assesses immediately the quality of the resection,
avoids this problem and allows complete resection with a single
surgical procedure in most cases.
Although the failure rate was higher after radiotherapy than
surgery, cure was still obtained at 4 years in 92.5% of the cases.
The overall cure rate after X-ray therapy was consistent with
published results, which range from 90% to 98% (Nevrkla and
Newton, 1974; Orton, 1978, Reymann, 1980; Dubin and Kopf,
1983; Fitzpatrick et al, 1984; Brady et al, 1987; Petrovich et al,
1987; Ashby et al, 1989; Mazeron et al, 1989; Rowe et al, 1989;
Lovett et al, 1990; Wilder et al, 1991; Silverman et al, 1992b).
More relapses occurred with brachytherapy in our study (8.8%
failure rate at 4 years) than published in the literature, in which
failure rates are less than 5% (Daly etal, 1984; Pierquin etal, 1987;
Mazeron et al, 1989; Crook et al, 1990). As indications for the
three radiation techniques were different (according to size, loca-
tion, performance status), their failure rates were not compared.
Cosmetic result
The cosmetic evaluation is indeed a subjective criterion as shown
by the differences between the five assessors. The opinion of the
physician who performed the treatment (surgeon orradiotherapist)
was not requested in order to avoid a biased judgment. The
appraisal of the three persons who were not involved in the trial
(photographer, data manager, secretary) was probably mainly
focused on the actual cosmetic appearance, whereas for thepatient
and the dermatologist other considerations, such as the patient-
physician relationship, psychosocial and technical aspects, may
have intervened. Despite this, the comparison of the cosmetic
results obtained with the two treatments but assessed by the same
observer is far more objective, and the fact that all the observers
considered that results after surgery were better than after radio-
therapy strengthens the value of this conclusion. Surgery yielded
better results than radiotherapy in all the main locations ofthe face
and even the nose. This result does not support the proponents of
radiotherapy for BCC located on the nose on the grounds that it
leads to less deformation and better cosmetic results than surgery
(Chahbazian and Brown, 1980; Goldsmith and Sherwin, 1983;
Brady et al, 1987; Pierquin et al, 1987; Mazeron et al, 1989;
Morrison et al, 1993; Fleming et al, 1995).
Surgical scars were often marked at the initial evaluation but
they improved with time. After 4 years, patients were satisfied in
87% of the cases and dermatologists in 79%. This is consistent
with the previously published rates of good aesthetic results
assessed by patients or physicians, which range from 77% to 93%
(Lawrence et al, 1986; Marchac, 1988; Hohmann et al, 1992;
Silverman et al, 1992a; Bonvallot et al, 1993), and the improve-
ment of the results with time confirms the study of Silverman
(Silverman et al, 1992a). The good cosmetic result is partly related
to almost systematic recourse to frozen section examination,
which allows surgeons to spare healthy skin tissue surrounding the
tumour. In our trial, the high rate (42%) of additional excisions
based on the results of the frozen section examination suggested
that surgery was initially as conservative as possible.
Cutaneous necrosis was present in 5% of the patients treated
with radiotherapy. This is in agreement with the rates published,
which range from 2% to 5% (Nevrkla and Newton, 1974; Brady et
al, 1987; Orton, 1978; Pierquin et al, 1987; Crook et al, 1990;
Lovett et al, 1990; Lang and Maize, 1991; Wilder et al, 1991). The
other major residual abnormalities were, as expected, dyspigmen-
tations and telangiectasia. The rate of good cosmetic results
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appears to be lower than those published, but comparison was
difficult because of the wide range of published rates of good
aesthetic results (60-93%) assessed by patients or physicians
(Chahbazian and Brown, 1980; Goldsmith and Sherwin, 1983;
Brady et al, 1987; Pierquin et al, 1987; Mazeron et al, 1989; Crook
et al, 1990; Lovett et al, 1990; Silverman et al, 1992b). The deteri-
oration of the cosmetic appearance with time with radiotherapy
confirms the previous results of Silverman (1992b) and the small
study ofCooper (1988).
This is the first randomized trial of previously untreated BCC
comparing surgery and radiotherapy. Surgery proved to be supe-
rior to radiotherapy in treatment efficacy and cosmetic result.
Thus, for untreated BCC of the face of less than 4 cm, surgery is
recommended as first-line treatment and radiotherapy ought to be
reserved for patients in whom surgery is contraindicated.
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